Compare · CGC vs OBIO
CGC vs OBIO
Side-by-side comparison of Canopy Growth Corporation (CGC) and Orchestra BioMed Holdings Inc. (OBIO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and OBIO operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 11.7x OBIO ($244.3M).
- CGC has been more active in the news (13 items in the past 4 weeks vs 7 for OBIO).
- CGC has more recent analyst coverage (19 ratings vs 9 for OBIO).
- Company
- Canopy Growth Corporation
- Orchestra BioMed Holdings Inc.
- Price
- -
- -
- Market cap
- $2.86B
- $244.3M
- 1M return
- -11.29%
- -
- 1Y return
- -19.79%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 13
- 7
- Recent ratings
- 19
- 9
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest CGC
- Director Atkins M Shan was granted 108,324 shares, increasing direct ownership by 262% to 149,714 units (SEC Form 4)
- Director Lazzarato David Angelo was granted 162,485 shares, increasing direct ownership by 226% to 234,533 units (SEC Form 4)
- Director Bayern Joseph was granted 108,324 shares, increasing direct ownership by 271% to 148,324 units (SEC Form 4)
- Director Yanofsky Theresa was granted 108,324 shares, increasing direct ownership by 204% to 161,469 units (SEC Form 4)
- Officer Stewart Thomas Carlton was granted 379,018 shares and sold $9,045 worth of shares (9,285 units at $0.97), increasing direct ownership by 150% to 616,398 units (SEC Form 4) to satisfy withholding tax
- Officer Gedeon Christelle was granted 396,012 shares and sold $57,466 worth of shares (58,994 units at $0.97), increasing direct ownership by 91% to 705,506 units (SEC Form 4) to satisfy withholding tax
- Chief Executive Officer Mongeau Luc was granted 1,056,152 shares and sold $131,729 worth of shares (135,231 units at $0.97), increasing direct ownership by 115% to 1,723,913 units (SEC Form 4) (tax liability)
- SEC Form S-8 filed by Canopy Growth Corporation
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis
Latest OBIO
- Sidoti Events, LLC's June Small-Cap Virtual Conference
- Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 36,352 shares, decreasing direct ownership by 6% to 593,065 units (SEC Form 4) to satisfy tax liability
- Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.31% to 1,060,746 units (SEC Form 4) (tax withholding)
- Officer Hochman David P bought $19,150 worth of shares (5,000 units at $3.83), increasing direct ownership by 0.47% to 1,064,029 units (SEC Form 4)
- Officer Sherman Darren sold $58,050 worth of shares (15,000 units at $3.87) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,184,327 units (SEC Form 4)
- Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SEC Form 144 filed by Orchestra BioMed Holdings Inc.
- Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,076 shares, decreasing direct ownership by 0.49% to 629,417 units (SEC Form 4) (for tax liability)
- Officer Sherman Darren covered exercise/tax liability with 4,925 shares, decreasing direct ownership by 0.41% to 1,199,327 units (SEC Form 4) to satisfy tax liability
- Director Aryeh Jason bought $2,494 worth of shares (665 units at $3.75), increasing direct ownership by 0.57% to 118,118 units (SEC Form 4)